Moscow, August 19, 2013– Pharmstandard OJSC (LSE: PHST LI, RTS: PHST RU) announces the results of its extraordinary general meeting of shareholders held on August 17, 2013.
Based on the voting results, the Extraordinary General Meeting of shareholders (EGM) has taken the following resolutions:
- To approve a deal - a contact of sale of BEVER PHARMACEUTICAL PTE LTD (22B Duxton Hill, Singapore) shares concluded between Pharmstandard OJSC (“buyer”) and BRISTLEY ENTERPISES LIMITED (Cyprus) (seller). The object of the deal: 50,000 shares with a nominal value of 1 Singapore dollar, that constitute 100% of BEVER PHARMACEUTICAL PTE LTD capital. The amount of the deal: not more that 630 million dollars.
The quorum of the general meeting: 73.2732%
Voting results:
•«FOR» - 52.8196 % of the total number of votes of those who are not interested in the transaction
•«AGAINST» - 17.5124 % of the total number of votes of those who are not interested in the transaction
•«ABSTAIN» - 1.8983 % of the total number of votes of those who are not interested in the transaction
Contacts:
Irina Bakhturina.
Investor Relations
Pharmstandard OJSC
Tel.: +7 (495) 970-0030 Ext.2824
E-mail: ir@pharmstd.ru
www.pharmstd.com
| 
.jpg){kind=small}
